OMER – Omeros Corporation
OMER — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
25.39
Margin Of Safety %
Put/Call OI Ratio
0.37
EPS Next Q Diff
-3.53
EPS Last/This Y
-1.49
EPS This/Next Y
2.85
Price
10.98
Target Price
43.67
Analyst Recom
1.8
Performance Q
-28.7
Upside
-259.4%
Beta
2.59
Ticker: OMER
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | OMER | 11.28 | 0.42 | 0.32 | 44780 |
| 2026-03-10 | OMER | 11.72 | 0.42 | 0.06 | 44732 |
| 2026-03-11 | OMER | 11.94 | 0.42 | 0.02 | 45058 |
| 2026-03-12 | OMER | 11.43 | 0.42 | 0.09 | 45207 |
| 2026-03-13 | OMER | 11.42 | 0.42 | 0.12 | 45207 |
| 2026-03-17 | OMER | 11.27 | 0.41 | 0.00 | 46323 |
| 2026-03-18 | OMER | 10.95 | 0.39 | 0.19 | 47609 |
| 2026-03-20 | OMER | 11.02 | 0.39 | 3.17 | 48225 |
| 2026-03-25 | OMER | 10.45 | 0.42 | 0.95 | 39622 |
| 2026-03-26 | OMER | 10.31 | 0.43 | 0.08 | 40051 |
| 2026-03-27 | OMER | 9.89 | 0.43 | 0.23 | 40381 |
| 2026-03-30 | OMER | 9.82 | 0.43 | 0.09 | 40937 |
| 2026-03-31 | OMER | 10.57 | 0.41 | 0.60 | 42286 |
| 2026-04-01 | OMER | 12.07 | 0.38 | 0.13 | 45692 |
| 2026-04-06 | OMER | 10.88 | 0.39 | 0.03 | 48201 |
| 2026-04-07 | OMER | 10.99 | 0.37 | 0.35 | 50267 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | OMER | 11.28 | 164.9 | - | -1.25 |
| 2026-03-10 | OMER | 11.72 | 164.9 | - | -1.25 |
| 2026-03-11 | OMER | 11.93 | 164.9 | - | -1.25 |
| 2026-03-12 | OMER | 11.42 | 164.9 | - | -1.25 |
| 2026-03-13 | OMER | 11.19 | 164.9 | - | -1.25 |
| 2026-03-17 | OMER | 11.28 | 164.9 | - | -1.25 |
| 2026-03-18 | OMER | 10.95 | 164.9 | - | -1.25 |
| 2026-03-19 | OMER | 11.10 | 164.9 | - | -1.25 |
| 2026-03-20 | OMER | 11.02 | 164.9 | - | -1.25 |
| 2026-03-23 | OMER | 10.66 | 164.9 | - | -1.25 |
| 2026-03-24 | OMER | 10.19 | 164.9 | - | -1.25 |
| 2026-03-25 | OMER | 10.46 | 164.9 | - | -1.25 |
| 2026-03-26 | OMER | 10.30 | 164.9 | - | -1.25 |
| 2026-03-27 | OMER | 9.89 | 164.9 | - | -1.25 |
| 2026-03-30 | OMER | 9.81 | 164.9 | - | -1.25 |
| 2026-03-31 | OMER | 10.58 | 164.9 | - | -1.25 |
| 2026-04-01 | OMER | 12.06 | 164.9 | - | -1.25 |
| 2026-04-02 | OMER | 10.88 | 164.9 | - | -1.25 |
| 2026-04-06 | OMER | 10.89 | 38.5 | - | -1.54 |
| 2026-04-07 | OMER | 10.98 | 38.5 | - | -1.54 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | OMER | -2.16 | 0.53 | 26.34 |
| 2026-03-10 | OMER | -2.16 | 0.53 | 26.34 |
| 2026-03-11 | OMER | -2.16 | 0.53 | 25.36 |
| 2026-03-12 | OMER | -2.16 | 0.53 | 25.36 |
| 2026-03-13 | OMER | -2.16 | 0.53 | 25.36 |
| 2026-03-18 | OMER | -2.16 | 0.65 | 25.36 |
| 2026-03-19 | OMER | -2.16 | 0.65 | 25.36 |
| 2026-03-20 | OMER | -2.16 | 0.65 | 25.36 |
| 2026-03-23 | OMER | -2.16 | 0.64 | 25.36 |
| 2026-03-24 | OMER | -2.16 | 0.64 | 25.36 |
| 2026-03-25 | OMER | -2.16 | 0.64 | 25.39 |
| 2026-03-26 | OMER | -2.16 | 0.64 | 25.39 |
| 2026-03-27 | OMER | -2.16 | 0.64 | 25.39 |
| 2026-03-30 | OMER | -2.16 | 0.64 | 25.39 |
| 2026-03-31 | OMER | -2.16 | 0.64 | 25.39 |
| 2026-04-01 | OMER | -2.16 | 0.64 | 25.39 |
| 2026-04-02 | OMER | -2.16 | 0.64 | 25.39 |
| 2026-04-06 | OMER | -2.16 | 0.63 | 25.39 |
| 2026-04-07 | OMER | -2.16 | 0.63 | 25.39 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
3.14
Avg. EPS Est. Current Quarter
0.16
Avg. EPS Est. Next Quarter
-0.39
Insider Transactions
-2.16
Institutional Transactions
0.63
Beta
2.59
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
3
Growth Score
23
Sentiment Score
86
Actual DrawDown %
43.4
Max Drawdown 5-Year %
-94.4
Target Price
43.67
P/E
Forward P/E
13.43
PEG
P/S
P/B
P/Free Cash Flow
EPS
-0.5
Average EPS Est. Cur. Y
-1.54
EPS Next Y. (Est.)
1.31
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.87
Return on Equity vs Sector %
-24.7
Return on Equity vs Industry %
-8.2
EPS 1 7Days Diff
-2
EPS 1 30Days Diff
-2.03
EBIT Estimation
◆
OMER
Healthcare
$10.98
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
49.5
Range 1M
31.3%
Sup Dist
3.2%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-415%
EPS NY
417.5%
52W%
53.3%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+311.9% upside
Upside
+311.9%
Quality
3
Omeros CorporationSector: Healthcare
Industry: Biotechnology
Employees: 175
Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. The company's lead products candidate is the Narsoplimab (OMS721/MASP-2) for the treatment of hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); and in Phase II clinical trial to treat COVID-19 and acute respiratory distress syndrome. It also develops OMS1029 that has completed phase I clinical trials for mannan-binding lectin-associated serine protease 2 (MASP-2) and lectin pathway disorders; and OMS527 that is in phase I clinical trials for addictions and compulsive disorders, and movement disorders, as well as cocaine use disorder. In addition, the company's products under preclinical development comprise MASP-2, a pro-inflammatory protein target for the treatment of lectin pathway disorders; MASP-3 small-molecule inhibitors for alternative pathway disorders; OncotoX-AML, to treat acute myeloid leukemia; and Targeted Complement Activating Therapy, for Multidrug-resistant organisms. Omeros Corporation was incorporated in 1994 and is headquartered in Seattle, Washington.
OMER
Latest News
—
Caricamento notizie per OMER…
stock quote shares OMER – Omeros Corporation Stock Price stock today
news today OMER – Omeros Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch OMER – Omeros Corporation yahoo finance google finance
stock history OMER – Omeros Corporation invest stock market
stock prices OMER premarket after hours
ticker OMER fair value insiders trading